The efficacy and safety of high-intensity interval training in chemotherapy-related cardiomyopathy: Report of two cases

Turk J Phys Med Rehabil. 2022 Jun 1;68(2):290-294. doi: 10.5606/tftrd.2022.7375. eCollection 2022 Jun.

Abstract

Studies suggest that exercise regimens are beneficial across all phases of cancer treatment and rehabilitation. However, studies on the efficacy and safety of cardiac rehabilitation in patients with chemotherapy-related cardiomyopathy are lacking. Herein, we present two patients diagnosed with chemotherapy-related cardiomyopathy who participated in a cardiac rehabilitation program, including eight weeks of high-intensity interval training, and their exercise capacity was monitored. Both patients showed significant increases in peak oxygen consumption and 6-min walk distance. High-intensity interval training results in objective improvements in aerobic exercise capacity without serious cardiovascular complications in patients with chemotherapy-related cardiomyopathy.

Keywords: Cardiac rehabilitation cardiomyopathy; chemotherapy; high-intensity interval training; oxygen consumption.

Publication types

  • Case Reports